Cargando…
Muscimol Directly Activates the TREK-2 Channel Expressed in GABAergic Neurons through Its N-Terminus
The two-pore domain K(+) (K(2P)) channel, which is involved in setting the resting membrane potential in neurons, is an essential target for receptor agonists. Activation of the γ-aminobutyric acid (GABA) receptors (GABA(A)R and GABA(B)R) reduces cellular excitability through Cl(-) influx and K(+) e...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431218/ https://www.ncbi.nlm.nih.gov/pubmed/34502229 http://dx.doi.org/10.3390/ijms22179320 |
_version_ | 1783750885374951424 |
---|---|
author | Kim, Eun-Jin Kwon, Oh-Sang Hur, Chang-Gi Nyiramana, Marie Merci Lee, Dong-Kun Hong, Seong-Geun Han, Jaehee Kang, Dawon |
author_facet | Kim, Eun-Jin Kwon, Oh-Sang Hur, Chang-Gi Nyiramana, Marie Merci Lee, Dong-Kun Hong, Seong-Geun Han, Jaehee Kang, Dawon |
author_sort | Kim, Eun-Jin |
collection | PubMed |
description | The two-pore domain K(+) (K(2P)) channel, which is involved in setting the resting membrane potential in neurons, is an essential target for receptor agonists. Activation of the γ-aminobutyric acid (GABA) receptors (GABA(A)R and GABA(B)R) reduces cellular excitability through Cl(-) influx and K(+) efflux in neurons. Relatively little is known about the link between GABA(A)R and the K(+) channel. The present study was performed to identify the effect of GABAR agonists on K(2P) channel expression and activity in the neuroblastic B35 cells that maintain glutamic acid decarboxylase (GAD) activity and express GABA. TASK and TREK/TRAAK mRNA were expressed in B35 cells with a high level of TREK-2 and TRAAK. In addition, TREK/TRAAK proteins were detected in the GABAergic neurons obtained from GABA transgenic mice. Furthermore, TREK-2 mRNA and protein expression levels were markedly upregulated in B35 cells by GABA(A)R and GABA(B)R agonists. In particular, muscimol, a GABA(A)R agonist, significantly increased TREK-2 expression and activity, but the effect was reduced in the presence of the GABA(A)R antagonist bicuculine or TREK-2 inhibitor norfluoxetine. In the whole-cell and single-channel patch configurations, muscimol increased TREK-2 activity, but the muscimol effect disappeared in the N-terminal deletion mutant. These results indicate that muscimol directly induces TREK-2 activation through the N-terminus and suggest that muscimol can reduce cellular excitability by activating the TREK-2 channel and by inducing Cl(-) influx in GABAergic neurons. |
format | Online Article Text |
id | pubmed-8431218 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-84312182021-09-11 Muscimol Directly Activates the TREK-2 Channel Expressed in GABAergic Neurons through Its N-Terminus Kim, Eun-Jin Kwon, Oh-Sang Hur, Chang-Gi Nyiramana, Marie Merci Lee, Dong-Kun Hong, Seong-Geun Han, Jaehee Kang, Dawon Int J Mol Sci Article The two-pore domain K(+) (K(2P)) channel, which is involved in setting the resting membrane potential in neurons, is an essential target for receptor agonists. Activation of the γ-aminobutyric acid (GABA) receptors (GABA(A)R and GABA(B)R) reduces cellular excitability through Cl(-) influx and K(+) efflux in neurons. Relatively little is known about the link between GABA(A)R and the K(+) channel. The present study was performed to identify the effect of GABAR agonists on K(2P) channel expression and activity in the neuroblastic B35 cells that maintain glutamic acid decarboxylase (GAD) activity and express GABA. TASK and TREK/TRAAK mRNA were expressed in B35 cells with a high level of TREK-2 and TRAAK. In addition, TREK/TRAAK proteins were detected in the GABAergic neurons obtained from GABA transgenic mice. Furthermore, TREK-2 mRNA and protein expression levels were markedly upregulated in B35 cells by GABA(A)R and GABA(B)R agonists. In particular, muscimol, a GABA(A)R agonist, significantly increased TREK-2 expression and activity, but the effect was reduced in the presence of the GABA(A)R antagonist bicuculine or TREK-2 inhibitor norfluoxetine. In the whole-cell and single-channel patch configurations, muscimol increased TREK-2 activity, but the muscimol effect disappeared in the N-terminal deletion mutant. These results indicate that muscimol directly induces TREK-2 activation through the N-terminus and suggest that muscimol can reduce cellular excitability by activating the TREK-2 channel and by inducing Cl(-) influx in GABAergic neurons. MDPI 2021-08-27 /pmc/articles/PMC8431218/ /pubmed/34502229 http://dx.doi.org/10.3390/ijms22179320 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Kim, Eun-Jin Kwon, Oh-Sang Hur, Chang-Gi Nyiramana, Marie Merci Lee, Dong-Kun Hong, Seong-Geun Han, Jaehee Kang, Dawon Muscimol Directly Activates the TREK-2 Channel Expressed in GABAergic Neurons through Its N-Terminus |
title | Muscimol Directly Activates the TREK-2 Channel Expressed in GABAergic Neurons through Its N-Terminus |
title_full | Muscimol Directly Activates the TREK-2 Channel Expressed in GABAergic Neurons through Its N-Terminus |
title_fullStr | Muscimol Directly Activates the TREK-2 Channel Expressed in GABAergic Neurons through Its N-Terminus |
title_full_unstemmed | Muscimol Directly Activates the TREK-2 Channel Expressed in GABAergic Neurons through Its N-Terminus |
title_short | Muscimol Directly Activates the TREK-2 Channel Expressed in GABAergic Neurons through Its N-Terminus |
title_sort | muscimol directly activates the trek-2 channel expressed in gabaergic neurons through its n-terminus |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431218/ https://www.ncbi.nlm.nih.gov/pubmed/34502229 http://dx.doi.org/10.3390/ijms22179320 |
work_keys_str_mv | AT kimeunjin muscimoldirectlyactivatesthetrek2channelexpressedingabaergicneuronsthroughitsnterminus AT kwonohsang muscimoldirectlyactivatesthetrek2channelexpressedingabaergicneuronsthroughitsnterminus AT hurchanggi muscimoldirectlyactivatesthetrek2channelexpressedingabaergicneuronsthroughitsnterminus AT nyiramanamariemerci muscimoldirectlyactivatesthetrek2channelexpressedingabaergicneuronsthroughitsnterminus AT leedongkun muscimoldirectlyactivatesthetrek2channelexpressedingabaergicneuronsthroughitsnterminus AT hongseonggeun muscimoldirectlyactivatesthetrek2channelexpressedingabaergicneuronsthroughitsnterminus AT hanjaehee muscimoldirectlyactivatesthetrek2channelexpressedingabaergicneuronsthroughitsnterminus AT kangdawon muscimoldirectlyactivatesthetrek2channelexpressedingabaergicneuronsthroughitsnterminus |